Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**RELEEV** is a Merix Pharmaceutical over-the-counter topical liquid for treatment of cold sores and fever blisters, including associated pain, tingling, itching, and burning. The current U.S. OTC drug label identifies benzalkonium chloride 0.13% as the sole active ingredient; it functions as a topical antimicrobial antiseptic that can help cleanse and dry lesions. The proprietary VIRACEA botanical formulation, which includes Echinacea purpurea extract, is described in product marketing but is listed among inactive ingredients on the current label. RELEEV is applied directly to affected external lesions and may also be used on sores inside the mouth.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on RELEEV.